T1	Disorder 0 18	Serotonin syndrome
N1 	Reference T1 UMLS:C0024586	Serotonin syndrome
N2 	Reference T1 UMLS:C0699828	Serotonin syndrome
T2	Pharmacological_substance 43 58	cyclobenzaprine
N1000 	Reference T2 MeSH:C004704	cyclobenzaprine
T3	Pharmacological_substance 70 90	serotoninergic drugs
T4	Disorder 92 110	Serotonin syndrome
N3 	Reference T4 UMLS:C0024586	Serotonin syndrome
N4 	Reference T4 UMLS:C0699828	Serotonin syndrome
T5	Disorder 328 346	serotonin syndrome
N5 	Reference T5 UMLS:C0024586	serotonin syndrome
N6 	Reference T5 UMLS:C0699828	serotonin syndrome
T6	Pharmacological_substance 380 395	cyclobenzaprine
N1001 	Reference T6 MeSH:C004704	cyclobenzaprine
T7	Pharmacological_substance 448 470	proserotoninergic drug
T8	Pharmacological_substance 472 482	phenelzine
N1002 	Reference T8 MeSH:D010624	phenelzine
T9	Pharmacological_substance 499 509	duloxetine
N1003 	Reference T9 MeSH:D000068736	duloxetine
T10	Pharmacological_substance 633 648	cyclobenzaprine
N1004 	Reference T10 MeSH:C004704	cyclobenzaprine
T11	Pharmacological_substance 748 763	cyclobenzaprine
N1005 	Reference T11 MeSH:C004704	cyclobenzaprine
T12	Pharmacological_substance 828 853	serotonin-enhancing drugs
T13	Disorder 920 938	serotonin syndrome
N7 	Reference T13 UMLS:C0024586	serotonin syndrome
N8 	Reference T13 UMLS:C0699828	serotonin syndrome
T18	Pharmacological_substance 191 220	proserotoninergic medications
T21	Speculation_cue 162 165	may
T25	Subject 399 421	postoperative patients
T26	Pharmacological_substance 706 728	proserotoninergic drug
T29	Disorder 552 573	autonomic instability
T30	Disorder 585 594	agitation
N9 	Reference T30 UMLS:C0085631	agitation
T40	Speculation_cue 870 876	should
T14	Combination 822 827	other
T23	Combination 440 447	another
